Skip to main content
Premium Trial:

Request an Annual Quote

Watching These

A panel of scientific advisors to the Indian government has marked some SARS-CoV-2 variants circulating there for a closer look, Reuters reports.

India has been experiencing a surge in COVID-19 cases, and reported some 400,000 new cases on Saturday, according to Reuters. Officials and scientists, it adds, are examining whether a viral variant may be fueling the rise in cases, as a variant called B.1.617 has been found there that, according to some modeling, may have a higher growth rate than other variants.

It now reports that the Indian SARS-CoV-2 Genetics Consortium (INSACOG) has identified some variants they suspect may evade immune response, but that more analysis is needed. "Unless you culture those viruses and test them in the lab, you can't say for sure. At this point, there is no reason to believe that they are expanding or if they can be dangerous, but we flagged it so that we keep our eye on the ball," Shahid Jameel, the chair of INSACOG, tells Reuters.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more